Publications by authors named "Alaaeldin Shablak"

Claim this Profile
D
Diagnosis and Management of Colorectal Cancer in the Gulf Area: Current Practice and Future Suggestions from Expert Opinions.
Humaid O Al-Shamsi, Kakil Rasul Snr, Alaaeldin Shablak, Abdulsalam ALnajjar, Amrou Mamdouh Abdeen Shabaan

Onco Targets Ther· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment with decitabine induces the expression of stemness markers, PD-L1 and NY-ESO-1 in colorectal cancer: potential for combined chemoimmunotherapy.
Nassiba Taib, Maysaloun Merhi, Varghese Inchakalody, Sarra Mestiri, Shereena Hydrose, Alaaeldin Shablak

J Transl Med· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The complex network of transcription factors, immune checkpoint inhibitors and stemness features in colorectal cancer: A recent update.
Maysaloun Merhi, Fareed Ahmad, Nassiba Taib, Varghese Inchakalody, Shahab Uddin, Alaaeldin Shablak

Semin Cancer Biol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID-19 Vaccination in Cancer Patients: A Review Article.
Rana Mekkawi, Bassant A Elkattan, Alaaeldin Shablak, Mohammad Bakr, Mohamed A Yassin

Cancer Control· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful rechallenge with cisplatin following cisplatin induced ischemic cerebrovascular accident in a patient with small cell lung cancer.
Farah Rashid, Nabil E Omar, Hassan Aaekl, Ussama Al Homsi, Alaaeldin Shablak

Clin Case Rep· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A primary squamous cell carcinoma of the sigmoid colon in a young patient: A case report and literature review.
Mohanad Faisal, Ahmed Abdalhadi, M Zaki Karzoun, Mohamed Aboagla Suliman Mohamed, Mouhammad Zuhair Sharaf Elden, Alaaeldin Shablak

Clin Case Rep· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Histopathologic Predictors of Survival and Recurrence in Resected Ampullary Adenocarcinoma: International Multicenter Cohort Study.
Alma L Moekotte, Sanne Lof, Stijn Van Roessel, Martina Fontana, Stephan Dreyer, Alaaeldin Shablak

Ann Surg· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro effect of IL-2 in combination with pazopanib or sunitinib on lymphocytes function and apoptosis of RCC cells.
Alaaeldin Shablak, David E Gilham, Robert E Hawkins, Eyad Elkord

Expert Opin Pharmacother· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A case of fatal cetuximab-induced interstitial lung disease during the first weeks of treatment.
Alaaeldin Shablak, Andrew Conn

Target Oncol· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eribulin for advanced breast cancer: a drug evaluation.
Alaaeldin Shablak

J Breast Cancer· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of a new isolated metastasis during sunitinib treatment in renal cell carcinoma patients: a lesson from two cases.
Alaaeldin Shablak, Jackie O'Dwyer, Robert Hawkins, Ruth Board

Urol Int· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-dose interleukin-2 can produce a high rate of response and durable remissions in appropriately selected patients with metastatic renal cancer.
Alaaeldin Shablak, Kanwal Sikand, Jonathan H Shanks, Fiona Thistlethwaite, Andrea Spencer-Shaw

J Immunother· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
5
5T4 as a target for immunotherapy in renal cell carcinoma.
Eyad Elkord, Alaaeldin Shablak, Peter L Stern, Robert E Hawkins

Expert Rev Anticancer Ther· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
T cell-based immunotherapy of metastatic renal cell carcinoma: modest success and future perspective.
Alaaeldin Shablak, Robert E Hawkins, Dominic G Rothwell, Eyad Elkord

Clin Cancer Res· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaccination of patients with metastatic renal cancer with modified vaccinia Ankara encoding the tumor antigen 5T4 (TroVax) given alongside interferon-alpha.
Robert E Hawkins, Catriona Macdermott, Alaaeldin Shablak, Caroline Hamer, Fiona Thistlethwaite

J Immunother· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adoptive transfer of T(reg) depleted autologous T cells in advanced renal cell carcinoma.
Fiona C Thistlethwaite, Eyad Elkord, Richard W Griffiths, Deborah J Burt, Alaaeldin M Shablak

Cancer Immunol Immunother· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis